Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 2/20 | 0.33 |
| ▸ | GLI1 | P08151 | 1/20 | 0.32 |
| ▸ | BCHE | P06276 | 1/20 | 0.31 |
| ▸ | GABRR1 | P24046 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30128341 | 0.84 | DPP4 (0.32) | DPP4GLI1 | |
| SCHEMBL329706 | 0.84 | DPP4 (0.32) | DPP4GLI1 | |
| SCHEMBL12035511 | 0.84 | DPP4 (0.32) | DPP4GLI1 | |
| SCHEMBL4760467 | 0.81 | DPP4 (0.34) | DPP4GLI1BCHE | |
| SCHEMBL20328944 | 0.80 | MME (0.31) | — | |
| SCHEMBL14504666 | 0.79 | BCHE (0.37) | DPP4BCHE | |
| SCHEMBL10046551 | 0.78 | ACE (0.44) | DPP4GLI1BCHEGABRR1 | |
| SCHEMBL1503908 | 0.78 | MME (0.33) | DPP4GLI1 | |
| SCHEMBL20328936 | 0.78 | FASN (0.38) | — | |
| SCHEMBL27903631 | 0.78 | MME (0.33) | DPP4GLI1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070105890-A1 | Novel condensed imidazole derivative | DAINIPPON SUMITOMO PHARMA CO., LTD | 2007-05-10 | — | — | US | disclosed |
| US-20070105890-A1 | Novel condensed imidazole derivative | DAINIPPON SUMITOMO PHARMA CO., LTD | 2007-05-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070105890-A1 | Novel condensed imidazole derivative | DPP4, DPP7, DPP3 | DPP4 1/4885GLI1 1552/4885BCHE 541/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.